1. Home
  2. Labeler Index
  3. Alivio Medical Products, Llc
  4. NDC Product Code: 69512-541 Cyclobenzaprine Hydrochloride

NDC 69512-541 Cyclobenzaprine Hydrochloride

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 69512-541?
  5. Cyclobenzaprine Hydrochloride Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
69512-541
Proprietary Name:
Cyclobenzaprine Hydrochloride
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Alivio Medical Products, Llc
Labeler Code:
69512
Product Label ID:
ec636fad-9537-4001-a691-c7b4cc2b6a96
Start Marketing Date: [9]
10-01-2015
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
YELLOW (C48330 - YELLOW (BUTTERSCOTCH))
Shape:
ROUND (C48348)
Size(s):
8 MM
Imprint(s):
AN41
Score:
1

Product Packages

NDC Code 69512-541-10

Package Description: 100 CAPSULE in 1 BOTTLE / 10 mg in 1 CAPSULE

Product Details

What is NDC 69512-541?

The NDC code 69512-541 is assigned by the FDA to the product Cyclobenzaprine Hydrochloride which is product labeled by Alivio Medical Products, Llc. The product's dosage form is . The product is distributed in a single package with assigned NDC code 69512-541-10 100 capsule in 1 bottle / 10 mg in 1 capsule. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Cyclobenzaprine Hydrochloride?

INDICATIONS AND USAGECyclobenzaprine hydrochloride tablets,USP are indicated as an adjunct to rest and physical therapy forrelief of muscle spasm associated with acute, painful muscoskeletal conditions.

Which are Cyclobenzaprine Hydrochloride UNII Codes?

The UNII codes for the active ingredients in this product are:

  • CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P)
  • CYCLOBENZAPRINE (UNII: 69O5WQQ5TI) (Active Moiety)

Which are Cyclobenzaprine Hydrochloride Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Cyclobenzaprine Hydrochloride?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Patient Education

Cyclobenzaprine


Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".